# Use of Dexcom G6 in Commercial Pilots With Insulin Treated Diabetes

> **NCT04395378** · — · SUSPENDED · sponsor: **University of Surrey** · enrollment: 30 (estimated)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DEVICE:** Continuous Glucose monitoring DEXCOM G6

## Key facts

- **NCT ID:** NCT04395378
- **Lead sponsor:** University of Surrey
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** SUSPENDED
- **Start date:** 2019-12-05
- **Primary completion:** 2022-12-02
- **Final completion:** 2022-12-02
- **Target enrollment:** 30 (ESTIMATED)
- **Why stopped:** COVID-19 policy of the University of Surrey
- **Last updated:** 2021-04-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04395378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04395378, "Use of Dexcom G6 in Commercial Pilots With Insulin Treated Diabetes". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04395378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*